Smith Bradford B

Show results for

Unknown (170)
Proteomics (22)
Transcriptomics (3)
Genomics (3)
Metabolomics (2)

Organisms

Andropogon gerardi (19)
Bacteria (19)
Bartonella quintana JK 31 (19)
Canis lupus familiaris (19)
Clavibacter nebraskensis NCPPB 2581 (19)
Cnidaria (19)
Ensifer adhaerens (19)
Human alphaherpesvirus 1 strain 17 (19)
Human alphaherpesvirus 1 strain KOS (19)
Human betaherpesvirus 5 (19)
Human herpesvirus 2 strain 186 (19)
Mesocricetus auratus (19)
Miscanthus x giganteus (19)
Mus musculus (19)
Panicum virgatum (19)
Platyhelminthes (19)
Pseudomonas aeruginosa PA103 (19)
Rabies virus Nishigahara RCEH (19)
Rattus norvegicus (19)
Rattus rattus (19)
Rhodococcus jostii RHA1 (19)
Rhodopseudomonas palustris (19)
Shigella (19)
Sorghastrum nutans (19)
Streptococcus dysgalactiae subsp. equisimilis SK1249 (19)
Streptococcus pneumoniae (19)
Streptomyces coelicolor A3(2) (19)
Tripsacum dactyloides (19)
Homo sapiens (6)
Bos taurus (1)

Repository

pride (19)
biostudies-arrayexpress (3)
EGA (3)
MassIVE (2)
MetaboLights (2)
PanoramaPublic (1)

Tissue

Cell culture (4)
Blood plasma (2)
Fibroblast (2)
Aorta (1)
Blood cell (1)
Culture fluid (1)
Epithelial cell (1)
Gastrocnemius (1)
Hypothalamus (1)
Intestine (1)
Liver (1)
Lung (1)
Lung epithelium (1)
Monocyte (1)
Plant cell (1)
Primary cell (1)
Shoot (1)
Skeletal muscle cell (1)
Synovial cell (1)
Telencephalon (1)
Whole body (1)

Disease

Avian influenza (1)
Bone osteosarcoma (1)
Cardiovascular system disease (1)
Disease free (1)
Idiopathic pulmonary fibrosis (1)
Influenza (1)
Lung adenocarcinoma (1)
Neurofibromatosis 1 (1)
Parasitic helminthiasis infectious disease (1)
Synovial sarcoma (1)
Viral infectious disease (1)

Technology Type

Mass Spectrometry (19)
Shotgun proteomics (9)
Bottom-up proteomics (5)
Data-dependent acquisition (4)
Affinity purification coupled with mass spectrometry proteomics (3)
Gel-based experiment (3)
Mass spectrometry (2)
Illumina HiSeq 2000, ILLUMINA, Illumina HiSeq 2500 (1)
Chemical cross-linking coupled with mass spectrometry proteomics (1)

Instrument Platform

Liquid Chromatography MS - negative - reverse phase (2)
Liquid Chromatography MS - positive - reverse phase (2)
ABI SOLiD v4 (1)
AB SOLiD 4 System (1)
LTQ Orbitrap Velos (1)

Publication Date

2022 (4)
2014 (3)
2025 (3)
2026 (3)
2023 (3)
2013 (2)
2020 (2)
2018 (2)
2019 (2)
2024 (1)
2017 (1)
2015 (1)

CHEBI ID

CHEBI:166925 (1)
CHEBI:53013 (1)
CHEBI:189612 (1)
CHEBI:138533 (1)
CHEBI:138537 (1)
CHEBI:183243 (1)
CHEBI:138794 (1)
CHEBI:183245 (1)
CHEBI:156126 (1)
CHEBI:183249 (1)
CHEBI:183643 (1)
CHEBI:183862 (1)
CHEBI:90456 (1)
CHEBI:166932 (1)
CHEBI:166933 (1)
CHEBI:166934 (1)
CHEBI:134446 (1)
CHEBI:134264 (1)
CHEBI:134265 (1)
CHEBI:189610 (1)
CHEBI:176773 (1)
CHEBI:189608 (1)
CHEBI:138337 (1)
CHEBI:138338 (1)
CHEBI:71751 (1)
CHEBI:137322 (1)
CHEBI:136222 (1)
CHEBI:189601 (1)
CHEBI:141299 (1)
CHEBI:136788 (1)

Metabolite Name

Guanosine-5'-Monophosphate (5'GMP) (1)
Adenosine 3'-monophosphate (3'AMP) (1)
2-Deoxyadenosine 5-monophosphate (dAMP) (1)
Uridine 5'-monophosphate (5'UMP) (1)
Cytidine 3'-monophosphate (3'CMP) (1)
Cytidine 2':3'-Cyclic monophosphate (2', 3'-cCMP) (1)
2'-Deoxycytidine 5'-monophosphate (dCMP) (1)
CL(66:5) (1)
CL(68:6) (1)
CL(70:4) (1)
CL(70:5) (1)
CL(70:6) (1)
CL(70:7) (1)
CL(70:9) (1)
CL(71:7) (1)
CL(72:10) (1)
CL(72:6) (1)
CL(72:7) (1)
CL(72:8) (1)
CL(72:9) (1)
CL(74:10) (1)
CL(74:11) (1)
CL(74:12) (1)
CL(74:8) (1)
CL(74:9) (1)
CL(76:10) (1)
CL(76:11) (1)
CL(76:12) (1)
CL(76:13) (1)
CL(78:13) (1)

Study type

Transcription profiling by array (2)
RNA-seq of coding RNA (1)

Release Date

2018 (33)
2022 (21)
2025 (16)
2021 (16)
2024 (15)
2014 (11)
2023 (10)
2013 (8)
2020 (8)
2016 (7)
2011 (7)
2019 (6)
2015 (5)
2012 (3)
2017 (2)
2009 (2)
2026 (1)
2010 (1)
2008 (1)

Lab affiliation

1Department of Medicine, University of Minnesota, 420 Delaware Street, SE, Minneapolis, Minnesota 55455, USA (1)
Baker Heart and Diabetes Institute, Aus (1)
Bioanalytical Mass Spectrometry Group, Max Planck Institute for Multidisciplinary Sciences, Am Fassberg 11, 37077 Goettingen, Germany (1)
Biochemistry and Molecular Biology, Michael Smith Laboratories, University of British Columbia (1)
Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver V5Z 1L3, Canada. (1)
Chair, Department of Environmental and Global Health, College of Public Health and Health Professions, University of Florida (1)
Department of Biochemistry & Molecular Biology, Michael Smith Laboratories, University of British Columbia, 2125 East Mall, Vancouver, British Columbia, Canada V6T 1Z4 (1)
Department of Biochemistry and Molecular Biology, Michael Smith Laboratories, University of British Columbia, Vancouver, BC, V6T 1Z4, Canada (1)
Department of Pharmacology University of North Carolina - Chapel Hill Chapel Hill, NC 27599 (1)
Dept. Cellular Molecular Pharmacology, University of California - San Francisco (UCSF), USA (1)
IBERS, Aberystwyth University (1)
Moffitt Cancer Center Tampa, FL, USA (1)
National Institute of Standards and Technology, NIST - Charleston (1)
Proteome Center Tuebingen (1)
Quantitative Proteomics & Proteome Center Tuebingen Interfaculty Institute for Cell Biology University of Tuebingen Tuebingen Germany (1)
Tow Center for Developmental Oncology, Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Departments of Pediatrics, Pharmacology, and Physiology & Biophysics, Weill Cornell Medical College, Cornell University, New York, NY, USA. (1)
University of Liverpool, Musculoskeletal Biology (1)
University of Nebraska-Lincoln (1)
Virginia Commonwealth University (1)

Previous page
1 / 20
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 20
Next page

Sort by:

Relevance

Page size

Initial insights into the impact and implementation of Creating Active Schools in Bradford, UK.

Not available

S-EPMC10320983 | biostudies-literature

Covid-19 lockdown: Ethnic differences in children's self-reported physical activity and the importance of leaving the home environment; a longitudinal and cross-sectional study from the Born in Bradford birth cohort study.

Not available

S-EPMC8419665 | biostudies-literature

An Analysis of Pharmacogenomic-Guided Pathways and Their Effect on Medication Changes and Hospital Admissions: A Systematic Review and Meta-Analysis.

Not available

S-EPMC8362615 | biostudies-literature

Autozygosity pilot Born in Bradford

The offspring of first cousin marriages have ~6% of their genome autozygous, i.e. homozygous identical by descent, or even more if there was further consanguinity in their ancestry. In the UK there are large populations with very high first cousin marriage rates of 20-50%. Sequencing the exomes of...

EGAS00001000462 | EGA

Child and family experiences of a whole-systems approach to physical activity in a multiethnic UK city: a citizen science evaluation protocol.

Not available

S-EPMC9945040 | biostudies-literature

Systems biology of blood and tissue for comprehensive analysis of immune response to hepatitis B vaccine in adults

Protein concentrations of both lysed WBC and plasma samples were measured by the PierceTM Bradford Assay and normalized to contain 10 μg per sample before proceeding with sample digestion using the procedure as previously described44. Peptides were desalted using STop-And-Go Extraction tips (STAGE t...

ORGANISM(S): Homo sapiens (Human)

2020-12-01 | PXD020474 | Pride